Modulation of d-penicillamine-induced autoimmunity in the Brown Norway rat using pharmacological agents that interfere with arachidonic acid metabolism or synthesis of inducible nitric oxide synthase
- 28 August 2003
- journal article
- Published by Elsevier in Toxicology
- Vol. 190 (3) , 267-278
- https://doi.org/10.1016/s0300-483x(03)00160-4
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 18 references indexed in Scilit:
- A Protective Role for Cyclooxygenase-2 in Drug-Induced Liver Injury in MiceChemical Research in Toxicology, 2001
- Resolution of inflammationInternational Journal of Immunopharmacology, 2000
- Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5–expressing cells in Brown Norway rats☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical PerspectiveChemical Research in Toxicology, 1998
- Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitorBritish Journal of Pharmacology, 1997
- Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory DrugsJournal of Biological Chemistry, 1997
- Markedly reduced intestinal toxicity of a diclofenac derivativeLife Sciences, 1994
- Pharmacokinetics and bioavailability of diclofenac in the ratJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Penicillamine nephropathyBMJ, 1988
- Effects of prolonged administration of d-penicillamine or captopril in various strains of ratsClinical Immunology and Immunopathology, 1984